Works about HER2 protein

Results: 1244

Effects of trastuzumab emtansine on canine urothelial carcinoma cells in vitro and in vivo.
Published in:
Veterinary & Comparative Oncology, 2024, v. 22, n. 2, p. 230, doi. 10.1111/vco.12970
By:
- Sakai, Kosei;
- Kato, Daiki;
- Yoshinaka, Junka;
- Takahashi, Yosuke;
- Ikeda, Namiko;
- Aoki, Susumu;
- Iguchi, Takaaki;
- Ishikawa, Shingo;
- Yamagishi, Norio;
- Shimamura, Shunsuke;
- Nakagawa, Takayuki
Publication type:
Article
Engineered cross-reacting nanobodies simplify comparative oncology between humans and dogs.
Published in:
Veterinary & Comparative Oncology, 2018, v. 16, n. 1, p. E202, doi. 10.1111/vco.12359
By:
- Mazzega, E.;
- de Marco, A.
Publication type:
Article
In vitro modeling of unsaturated free fatty acid-mediated tissue impairments seen in acne lesions.
Published in:
Archives of Dermatological Research, 2017, v. 309, n. 7, p. 529, doi. 10.1007/s00403-017-1747-y
By:
- Li, Wen-Hwa;
- Zhang, Qihong;
- Flach, Carol;
- Mendelsohn, Richard;
- Southall, Michael;
- Parsa, Ramine
Publication type:
Article
Withaferin A abolishes the stem cell factor-stimulated pigmentation of human epidermal equivalents by interrupting the auto-phosphorylation of c-KIT in human melanocytes.
Published in:
Archives of Dermatological Research, 2015, v. 307, n. 1, p. 73, doi. 10.1007/s00403-014-1518-y
By:
- Terazawa, Shuko;
- Nakajima, Hiroaki;
- Fukasawa, Katsunori;
- Imokawa, Genji
Publication type:
Article
Isolation of Genes Encoding for Human Epidermal Growth Factor (hEGF) from Human Blood: In Vitro and In Silico Study.
Published in:
Trends in Sciences, 2023, v. 20, n. 7, p. 1, doi. 10.48048/tis.2023.6563
By:
- Imelda Maelani;
- Suhartono Suhartono;
- Zulkarnain Zulkarnain
Publication type:
Article
Immunohistochemical expression of estrogen receptors, progesterone receptors, and human epidermal growth-factor receptor 2/neu in epithelial ovarian tumors.
Published in:
Journal of Medicine in Scientific Research, 2022, v. 5, n. 3, p. 309, doi. 10.4103/jmisr.jmisr_22_22
By:
- Mohieldin, Zaineb Y.;
- Hamid, Hanan S. Abdel;
- Mohamed, Sherien A.;
- Talaat, Suzan M.
Publication type:
Article
Functional expression of a single-chain antibody fragment against human epidermal growth factor receptor 2 (HER2) in Escherichia coli.
Published in:
Journal of Industrial Microbiology & Biotechnology, 2014, v. 41, n. 6, p. 947, doi. 10.1007/s10295-014-1437-0
By:
- Akbari, Vajihe;
- Mir Mohammad Sadeghi, Hamid;
- Jafrian-Dehkordi, Abbas;
- Abedi, Daryoush;
- Chou, C.
Publication type:
Article
Efficacy of anti-HER2 therapy in metastatic breast cancer by discordance of HER2 expression between primary and metastatic breast cancer.
Published in:
Breast Cancer Research Review, 2021, n. 32, p. 2
By:
- D. O.
Publication type:
Article
An Electrochemical Method for the Detection of Disease-Specific Exosomes.
Published in:
ChemElectroChem, 2017, v. 4, n. 4, p. 967, doi. 10.1002/celc.201600391
By:
- Yadav, Sharda;
- Boriachek, Kseniia;
- Islam, Md Nazmul;
- Lobb, Richard;
- Möller, Andreas;
- Hill, Michelle M.;
- Hossain, Md Shahriar Al;
- Nguyen, Nam‐Trung;
- Shiddiky, Muhammad J. A.
Publication type:
Article
Specific Picomolar Detection of a Breast Cancer Biomarker HER-2/ neu Protein in Serum: Electrocatalytically Amplified Electroanalysis by the Aptamer/PEG-Modified Electrode.
Published in:
ChemElectroChem, 2017, v. 4, n. 4, p. 872, doi. 10.1002/celc.201700025
By:
- Salimian, Razieh;
- Kékedy‐Nagy, László;
- Ferapontova, Elena E.
Publication type:
Article
Measurement of Domain-Specific HER2 (ERBB2) Expression May Classify Benefit From Trastuzumab in Breast Cancer.
Published in:
JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 8, p. 1, doi. 10.1093/jnci/djv136
By:
- Carvajal-Hausdorf, Daniel E.;
- Schalper, Kurt A.;
- Pusztai, Lajos;
- Psyrri, Amanda;
- Kalogeras, Konstantine T.;
- Kotoula, Vasiliki;
- Fountzilas, George;
- Rimm, David L.
Publication type:
Article
Blockade of a Key Region in the Extracellular Domain Inhibits HER2 Dimerization and Signaling.
Published in:
JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 6, p. 1, doi. 10.1093/jnci/djv090
By:
- Menendez, Javier A.;
- Schroeder, Barbara;
- Peirce, Susan K.;
- Vellon, Luciano;
- Papadimitropoulou, Adriana;
- Espinoza, Ingrid;
- Lupu, Ruth
Publication type:
Article
RE: How Many Etiological Subtypes of Breast Cancer: Two, Three, Four, or More?
Published in:
JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 4, p. 1, doi. 10.1093/jnci/djv031
By:
- Caldarella, A.;
- Crocetti, E.
Publication type:
Article
Effect of p95HER2/611CTF on the Response toTrastuzumab and Chemotherapy.
Published in:
JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 11, p. 1, doi. 10.1093/jnci/dju291
By:
- Parra-Palau, Josep Lluís;
- Morancho, Beatriz;
- Peg, Vicente;
- Escorihuela, Marta;
- Scaltriti, Maurizio;
- Vicario, Rocio;
- Zacarias-Fluck, Mariano;
- Pedersen, Kim;
- Pandiella, Atanasio;
- Nuciforo, Paolo;
- Serra, Violeta;
- Cortes, Javier;
- Baselga, José;
- Perou, Charles M.;
- Prat, Aleix;
- Rubio, Isabel T.;
- Arribas, Joaquín
Publication type:
Article
Biomarker Testing for Breast, Lung, and Gastroesophageal Cancers at NCI Designated Cancer Centers.
Published in:
JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 10, p. 1, doi. 10.1093/jnci/dju256
By:
- Schink, Julian C.;
- Trosman, Julia R.;
- Weldon, Christine B.;
- Siziopikou, Kalliopi P.;
- Tsongalis, Gregory J.;
- Rademaker, Alfred W.;
- Patel, Jyoti D.;
- Benson III, Al B.;
- Perez, Edith A.;
- Gradishar, William J.
Publication type:
Article
Molecular Features and Survival Outcomes of the Intrinsic Subtypes Within HER2-Positive Breast Cancer.
Published in:
JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 8, p. 1, doi. 10.1093/jnci/dju152
By:
- Prat, Aleix;
- Carey, Lisa A.;
- Adamo, Barbara;
- Vidal, Maria;
- Tabernero, Josep;
- Cortés, Javier;
- Parker, Joel S.;
- Perou, Charles M.;
- Baselga, José
Publication type:
Article
Dietary Fat Intake and Development of Specific Breast Cancer Subtypes.
Published in:
JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 5, p. 1, doi. 10.1093/jnci/dju068
By:
- Sieri, Sabina;
- Chiodini, Paolo;
- Agnoli, Claudia;
- Pala, Valeria;
- Berrino, Franco;
- Trichopoulou, Antonia;
- Benetou, Vassiliki;
- Vasilopoulou, Effie;
- Sánchez, Maria-José;
- Chirlaque, Maria-Dolores;
- Amiano, Pilar;
- Quirós, J. Ramón;
- Ardanaz, Eva;
- Buckland, Geneviève;
- Masala, Giovanna;
- Pánico, Salvatore;
- Grioni, Sara;
- Sacerdote, Carlotta;
- Tumino, Rosario;
- Boutron-Ruault, Marie-Christine
Publication type:
Article
Tracking and Evaluating Molecular Tumor Markers With Cancer Registry Data: HER2 and Breast Cancer.
Published in:
JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 5, p. 1, doi. 10.1093/jnci/dju093
By:
- Anderson, William F.;
- Rosenberg, Philip S.;
- Katki, Hormuzd A.
Publication type:
Article
US Incidence of Breast Cancer Subtypes Defined by Joint Hormone Receptor and HER2 Status.
Published in:
JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 5, p. 1, doi. 10.1093/jnci/dju055
By:
- Howlader, Nadia;
- Altekruse, Sean F.;
- Li, Christopher I.;
- Chen, Vivien W.;
- Clarke, Christina A.;
- Ries, Lynn A. G.;
- Cronin, Kathleen A.
Publication type:
Article
Selective Inhibition of HER2-Positive Breast Cancer Cells by the HIV Protease Inhibitor Nelfinavir.
Published in:
JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 20, p. 1576, doi. 10.1093/jnci/djs396
By:
- Joong Sup Shim;
- Rao, Rajini;
- Beebe, Kristin;
- Neckers, Len;
- Hart, Inkyu;
- Nahta, Rita;
- Liu, Jun O.
Publication type:
Article
Gastric Cancer: Trastuzumab Trial Results Spur Search for Other Targets.
Published in:
JNCI: Journal of the National Cancer Institute, 2009, v. 101, n. 19, p. 1306, doi. 10.1093/jnci/djp341
By:
- Hede, Karyn
Publication type:
Article
Anthracyclines in the Treatment of HER2-Negative Breast Cancer.
Published in:
JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 1, p. 2, doi. 10.1093/jnci/djm277
By:
- Soonmyung Paik;
- Taniyama, Yusuke;
- Geyer Jr., Charles E.
Publication type:
Article
Inconsistency of HER2 Test Raises Questions.
Published in:
JNCI: Journal of the National Cancer Institute, 2007, v. 99, n. 14, p. 1064, doi. 10.1093/jnci/djm075
By:
- Tuma, Rabiya S.
Publication type:
Article
Treatment of Human Epidermal Growth Factor Receptor 2-Overexpressing Breast Cancer Xenografts With Multiagent HER-Targeted Therapy.
Published in:
JNCI: Journal of the National Cancer Institute, 2007, v. 99, n. 9, p. 694, doi. 10.1093/jnci/djk151
By:
- Arpino, Grazia;
- Gutierrez, Carolina;
- Weiss, Heidi;
- Rimawi, Mothaffar;
- Massarweh, Suleiman;
- Bharwani, Lavina;
- De Placido, Sabino;
- Osborne, C. Kent;
- Schiff, Rachel
Publication type:
Article
DFT Simulation of Berberine Chloride with Spectroscopic Characterization – Biological activity and Molecular Docking against Breast Cancer.
Published in:
Polycyclic Aromatic Compounds, 2024, v. 44, n. 3, p. 1556, doi. 10.1080/10406638.2023.2201457
By:
- Zochedh, Azar;
- Chandran, Kaliraj;
- Priya, Mohana;
- Sultan, Asath Bahadur;
- Kathiresan, Thandavarayan
Publication type:
Article
Benzo[g]quinazolin-based scaffold derivatives as dual EGFR/HER2 inhibitors.
Published in:
Journal of Enzyme Inhibition & Medicinal Chemistry, 2018, v. 33, n. 1, p. 67, doi. 10.1080/14756366.2017.1389922
By:
- Ghorab, Mostafa M.;
- Alsaid, Mansour S.;
- Soliman, Aiten M.;
- Al-Mishari, Abdullah A.
Publication type:
Article
Anti–HER2 single domain antibody-conjugated dendrimers for targeted delivery of truncated-Bid transgene to breast cancer cells.
Published in:
Journal of Bioactive & Compatible Polymers, 2019, v. 34, n. 1, p. 39, doi. 10.1177/0883911518813677
By:
- Jafari Iri Sofla, Farnoush;
- Rahbarizadeh, Fatemeh;
- Ahmadvand, Davoud;
- Nomani, Alireza;
- Vernet, Erik
Publication type:
Article
Specific gene delivery mediated by poly(ethylene glycol)-grafted polyamidoamine dendrimer modified with a novel HER2-targeting nanobody.
Published in:
Journal of Bioactive & Compatible Polymers, 2015, v. 30, n. 2, p. 129, doi. 10.1177/0883911515569005
By:
- Jafari Iri Sofla, Farnoush;
- Rahbarizadeh, Fatemeh;
- Ahmadvand, Davoud;
- Nomani, Alireza;
- Rahimi Jamnani, Fatemeh
Publication type:
Article
Lapatinib plus Letrozole as First-Line Therapy for HER-2<sup>+</sup> Hormone Receptor--Positive Metastatic Breast Cancer.
Published in:
Oncologist, 2010, v. 15, n. 2, p. 122, doi. 10.1634/theoncologist.2009-0240
By:
- Schwartzberg, Lee S.;
- Franco, Sandra X.;
- Florance, Allison;
- O'Rourke, Lisa;
- Maltzman, Julie;
- Johnston, Stephen
Publication type:
Article
Commentary: Can Circulating HER-2 Extracellular Domain Predict Response to Trastuzumab in HER-2--Negative Breast Cancer?
Published in:
Oncologist, 2008, v. 13, n. 4, p. 370, doi. 10.1634/theoncologist.2008-0050
By:
- Esteva, Francisco J.
Publication type:
Article
HER-2-Positive Metastatic Breast Cancer: Optimizing Trastuzumab-Based Therapy.
Published in:
Oncologist, 2006, v. 11, p. 34, doi. 10.1634/theoncologist.11-90001-34
By:
- Jackisch, Christian
Publication type:
Article
Adjuvant Trastuzumab: A Milestone in the Treatment of HER-2-Positive Early Breast Cancer.
Published in:
Oncologist, 2006, v. 11, p. 4, doi. 10.1634/theoncologist.11-90001-4
By:
- Baselga, José;
- Perez, Edith A.;
- Pienkowski, Tadeusz;
- Bell, Richard
Publication type:
Article
Adjuvant Trastuzumab: A Milestone in the Treatment of HER-2-Positive Early Breast Cancer.
Published in:
Oncologist, 2006, v. 11, p. 4, doi. 10.1634/theoncologist.11-90001-4
By:
- Baselga, José;
- Perez, Edith A.;
- Pienkowski, Tadeusz;
- Bell, Richard
Publication type:
Article
HER-2-Positive Metastatic Breast Cancer: Optimizing Trastuzumab-Based Therapy.
Published in:
Oncologist, 2006, v. 11, p. 34, doi. 10.1634/theoncologist.11-90001-34
By:
- Jackisch, Christian
Publication type:
Article
Adjuvant Therapy with Trastuzumab for HER-2/neu-Positive Breast Cancer.
Published in:
Oncologist, 2006, v. 11, n. 8, p. 857, doi. 10.1634/theoncologist.11-8-857
By:
- GONZALEZ-ANGULO, ANA M.;
- HORTOBÁGYI, GABRIEL N.;
- ESTEVA, FRANCISCO J.
Publication type:
Article
Development and Analytical Validation of a BT-474 Anti-Proliferation Assay Targeting HER2.
Published in:
Analytical Letters, 2012, v. 45, n. 12, p. 1590, doi. 10.1080/00032719.2012.677787
By:
- Lv, Pin;
- Liu, PeiPei;
- Wang, Hongfang;
- Qiu, Lijuan;
- Wang, George
Publication type:
Article
Tubular carcinoma and grade 1 (well-differentiated) invasive ductal carcinoma: Comparison of flat epithelial atypia and other intra-epithelial lesions.
Published in:
Pathology International, 2008, v. 58, n. 10, p. 620, doi. 10.1111/j.1440-1827.2008.02280.x
By:
- Kunju, Lakshmi P.;
- Ding, Ying;
- Kleer, Celina G.
Publication type:
Article
Application of the AMeX method to the evaluation of HER-2 status in breast carcinomas: Comparison with the results of HercepTest.
Published in:
Pathology International, 2003, v. 53, n. 1, p. 27, doi. 10.1046/j.1440-1827.2003.01429.x
By:
- Mizogami, Masayo;
- Sakurai, Shinji;
- Kikuchi, Midori;
- Ohta, Kenichi;
- Sakurai, Tatsuo;
- Tanaka, Akira;
- Saito, Ken
Publication type:
Article
Multiple developmental pathways of highly aggressive breast cancers disclosed by comparison of histological grades and c-erbB-2 expression patterns in both the non-invasive and invasive portions.
Published in:
Pathology International, 1998, v. 48, n. 7, p. 518, doi. 10.1111/j.1440-1827.1998.tb03943.x
By:
- Tsuda, Hitoshi;
- Hirohashi, Setsuo
Publication type:
Article
A versatile gold leaf immunosensor with a novel surface functionalization strategy based on protein L and trastuzumab for HER2 detection.
Published in:
Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-024-83961-9
By:
- Kundacina, Ivana;
- Schobesberger, Silvia;
- Kittler, Stefan;
- Thumfart, Helena;
- Spadiut, Oliver;
- Ertl, Peter;
- Knežević, Nikola Ž.;
- Radonic, Vasa
Publication type:
Article
Tumor-Specific Delivery of Immune Checkpoint Inhibitors by Engineered AAV Vectors.
Published in:
Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00052
By:
- Reul, Johanna;
- Frisch, Janina;
- Engeland, Christine E.;
- Thalheimer, Frederic B.;
- Hartmann, Jessica;
- Ungerechts, Guy;
- Buchholz, Christian J.
Publication type:
Article
Racially restricted contribution of immunoglobulin Fcγ and Fcγ receptor genotypes to humoral immunity to human epidermal growth factor receptor 2 in breast cancer.
Published in:
Clinical & Experimental Immunology, 2013, v. 171, n. 3, p. 273, doi. 10.1111/cei.12018
By:
- Pandey, J. P.;
- Namboodiri, A. M.;
- Kistner‐Griffin, E.;
- Iwasaki, M.;
- Kasuga, Y.;
- Hamada, G. S.;
- Tsugane, S.
Publication type:
Article
ERBIN: a basolateral PDZ protein that interacts with the mammalian ERBB2/HER2 receptor.
Published in:
Nature Cell Biology, 2000, v. 2, n. 7, p. 407, doi. 10.1038/35017038
By:
- Borg, Jean-Paul;
- Marchetto, Sylvie;
- Le Bivic, André;
- Ollendorff, Vincent;
- Jaulin-Bastard, Fanny;
- Saito, Hiroko;
- Fournier, Emmanuel;
- Adélaïde, José;
- Margolis, Ben;
- Birnbaum, Daniel
Publication type:
Article
A D-Shaped Polymer Optical Fiber Surface Plasmon Resonance Biosensor for Breast Cancer Detection Applications.
Published in:
Biosensors (2079-6374), 2024, v. 14, n. 1, p. 15, doi. 10.3390/bios14010015
By:
- Wu, Xun;
- Wang, Ying;
- Zhang, Jiaxiong;
- Zhang, Yunfang;
- Rao, Xing;
- Chen, Chen;
- Liu, Han;
- Deng, Yubin;
- Liao, Changrui;
- Smietana, Mateusz Jakub;
- Chen, George Yuhui;
- Liu, Liwei;
- Qu, Junle;
- Wang, Yiping
Publication type:
Article
f HER2, PR, ER, Ki-67 and Cytokeratin 5/6 Expression in Benign Feline Mammary Lesions.
Published in:
Animals (2076-2615), 2022, v. 12, n. 13, p. N.PAG, doi. 10.3390/ani12131599
By:
- Soares, Maria;
- Correia, Assunção N.;
- Batista, Mariana R.;
- Correia, Jorge;
- Ferreira, Fernando
Publication type:
Article
Immunohistochemical Screening of HER2 in Canine Carcinomas: A Preliminary Study.
Published in:
Animals (2076-2615), 2021, v. 11, n. 4, p. 1006, doi. 10.3390/ani11041006
By:
- Brunetti, Barbara;
- Bacci, Barbara;
- Sarli, Giuseppe;
- Pancioni, Elisa;
- Muscatello, Luisa Vera
Publication type:
Article
Clinical Significance of p53 Protein Expression, Beta-catenin Expression and HER2 Expression for Epstein-Barr Virus-associated Gastric Cancer.
Published in:
Chonnam Medical Journal, 2017, v. 53, n. 2, p. 140, doi. 10.4068/cmj.2017.53.2.140
By:
- Dong Won Baek;
- Byung Woog Kang;
- Soyoon Hwang;
- Jong Gwang Kim;
- An Na Seo;
- Han Ik Bae;
- Oh Kyoung Kwon;
- Seung Soo Lee;
- Ho Young Chung;
- Wansik Yu
Publication type:
Article
Ribociclib with an Aromatase Inhibitor for Previously Untreated, HR-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Published in:
2019
By:
- Büyükkaramikli, Nasuh C.;
- de Groot, Saskia;
- Riemsma, Rob;
- Fayter, Debra;
- Armstrong, Nigel;
- Portegijs, Piet;
- Duffy, Steven;
- Kleijnen, Jos;
- Al, Maiwenn J.
Publication type:
journal article
Trastuzumab Emtansine for Treating HER2-Positive, Unresectable, Locally Advanced or Metastatic Breast Cancer After Treatment with Trastuzumab and a Taxane: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Published in:
2016
By:
- Squires, Hazel;
- Stevenson, Matt;
- Simpson, Emma;
- Harvey, Rebecca;
- Stevens, John
Publication type:
journal article
Pertuzumab in Combination with Trastuzumab and Docetaxel for the Treatment of HER2-Positive Metastatic or Locally Recurrent Unresectable Breast Cancer.
Published in:
PharmacoEconomics, 2015, v. 33, n. 1, p. 13, doi. 10.1007/s40273-014-0206-2
By:
- Fleeman, Nigel;
- Bagust, Adrian;
- Beale, Sophie;
- Dwan, Kerry;
- Dickson, Rumona;
- Proudlove, Chris;
- Dundar, Yenal
Publication type:
Article